Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0002 (1,900.00%)
Jan 23, 2025, 8:00 PM EST
Infinity Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Cash & Equivalents | 17.75 | 38.31 | 80.73 | 28.59 | 22.26 | 48.62 | Upgrade
|
| Short-Term Investments | - | - | - | 5.52 | 20.18 | 9.98 | Upgrade
|
| Cash & Short-Term Investments | 17.75 | 38.31 | 80.73 | 34.11 | 42.44 | 58.59 | Upgrade
|
| Cash Growth | -68.63% | -52.54% | 136.68% | -19.64% | -27.56% | 1.70% | Upgrade
|
| Prepaid Expenses | 1.79 | 1.43 | 1.14 | 1.53 | 1.68 | 0.64 | Upgrade
|
| Restricted Cash | - | - | - | 0.15 | - | - | Upgrade
|
| Other Current Assets | 0.38 | 0.56 | 0.4 | 0.23 | 0.46 | 0.59 | Upgrade
|
| Total Current Assets | 19.91 | 40.3 | 82.27 | 36.02 | 44.58 | 59.82 | Upgrade
|
| Property, Plant & Equipment | 1.08 | 1.5 | 2.31 | 3.13 | 3.9 | 0.03 | Upgrade
|
| Other Long-Term Assets | 0.24 | 0.35 | 0.21 | 0.17 | 0.53 | 0.37 | Upgrade
|
| Total Assets | 21.23 | 42.15 | 84.79 | 39.32 | 49.01 | 60.22 | Upgrade
|
| Accounts Payable | 1.5 | 4.41 | 2.32 | 2.98 | 1.62 | 1.2 | Upgrade
|
| Accrued Expenses | 8.63 | 7.41 | 9.56 | 6.73 | 7.7 | 6.52 | Upgrade
|
| Current Portion of Long-Term Debt | 1.25 | 1.22 | 0.9 | 0.85 | - | - | Upgrade
|
| Current Portion of Leases | 0.63 | 0.59 | 0.52 | 0.49 | 0.38 | - | Upgrade
|
| Other Current Liabilities | 0.05 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 12.06 | 13.63 | 13.3 | 11.05 | 9.7 | 7.72 | Upgrade
|
| Long-Term Debt | 46.57 | 47.21 | 48.73 | 49.58 | 29.63 | - | Upgrade
|
| Long-Term Leases | - | 0.32 | 0.92 | 1.44 | 1.93 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.04 | 0.27 | 0.25 | 0.04 | 0.04 | Upgrade
|
| Total Liabilities | 58.64 | 61.2 | 63.21 | 62.31 | 41.29 | 7.76 | Upgrade
|
| Common Stock | 0.09 | 0.09 | 0.09 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 839.46 | 836.81 | 833.07 | 743.27 | 733.49 | 731.18 | Upgrade
|
| Retained Earnings | -876.95 | -855.95 | -811.58 | -766.32 | -725.83 | -678.77 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -0 | 0.01 | -0 | Upgrade
|
| Shareholders' Equity | -37.41 | -19.05 | 21.57 | -22.99 | 7.73 | 52.46 | Upgrade
|
| Total Liabilities & Equity | 21.23 | 42.15 | 84.79 | 39.32 | 49.01 | 60.22 | Upgrade
|
| Total Debt | 48.46 | 49.35 | 51.06 | 52.35 | 31.93 | - | Upgrade
|
| Net Cash (Debt) | -30.71 | -11.04 | 29.67 | -18.25 | 10.51 | 58.59 | Upgrade
|
| Net Cash Growth | - | - | - | - | -82.06% | 13.53% | Upgrade
|
| Net Cash Per Share | -0.34 | -0.12 | 0.35 | -0.30 | 0.18 | 1.06 | Upgrade
|
| Filing Date Shares Outstanding | 90.76 | 89.42 | 89.16 | 88.64 | 57.43 | 56.93 | Upgrade
|
| Total Common Shares Outstanding | 90.76 | 89.41 | 89.16 | 64.32 | 57.08 | 56.91 | Upgrade
|
| Working Capital | 7.84 | 26.67 | 68.97 | 24.97 | 34.88 | 52.1 | Upgrade
|
| Book Value Per Share | -0.41 | -0.21 | 0.24 | -0.36 | 0.14 | 0.92 | Upgrade
|
| Tangible Book Value | -37.41 | -19.05 | 21.57 | -22.99 | 7.73 | 52.46 | Upgrade
|
| Tangible Book Value Per Share | -0.41 | -0.21 | 0.24 | -0.36 | 0.14 | 0.92 | Upgrade
|
| Machinery | - | 2.37 | 2.35 | 2.34 | 2.34 | 1.81 | Upgrade
|
| Leasehold Improvements | - | 1.74 | 1.74 | 1.74 | 1.74 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.